BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2963534)

  • 21. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.
    Valone FH; Friedman MA; Wittlinger PS; Drakes T; Eisenberg PD; Malec M; Hannigan JF; Brown BW
    J Clin Oncol; 1989 Oct; 7(10):1427-36. PubMed ID: 2789272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II study of sequential methotrexate and fluorouracil in advanced colorectal cancer.
    Panasci L; Ford J; Margolese R
    Cancer Chemother Pharmacol; 1985; 15(2):164-6. PubMed ID: 4017165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: a phase III trial by the Eastern Cooperative Oncology Group (EST: 4275).
    Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
    Cancer; 1982 Apr; 49(8):1555-60. PubMed ID: 7039814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential methotrexate, 5-fluorouracil, and calcium leucovorin in colorectal carcinoma.
    Hansen RM; Ritch PS; Anderson T
    Am J Clin Oncol; 1986 Aug; 9(4):352-4. PubMed ID: 3489407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination chemotherapy with 5-fluorouracil, CCNU, and vincristine in metastatic colorectal carcinoma.
    Xavier AM; Kasimis BS; Wu SY; Kaneshiro CA
    Am J Clin Oncol; 1984 Oct; 7(5):513-5. PubMed ID: 6391144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination chemotherapy of colorectal cancer with 5-fluorouracil, methyl-1,3-cis(2-chloroethyl)-1-nitrosourea, and vincristine.
    Joss RA; Goldberg RS; Yates JW
    Med Pediatr Oncol; 1979; 7(3):251-5. PubMed ID: 542190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate/fluorouracil scheduling influences normal tissue toxicity but not antitumor effects in patients with squamous cell head and neck cancer: results from a randomized trial.
    Browman GP; Levine MN; Goodyear MD; Russell R; Archibald SD; Jackson BS; Young JE; Basrur V; Johanson C
    J Clin Oncol; 1988 Jun; 6(6):963-8. PubMed ID: 3286831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial.
    Nordic Gastrointestinal Tumor Adjuvant Therapy Group
    J Clin Oncol; 1989 Oct; 7(10):1437-46. PubMed ID: 2674332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A northern California Oncology Group randomized trial of single agent 5-FU vs. high-dose folinic acid + 5-FU vs. methotrexate + 5-FU + folinic acid in patients with disseminated measurable large bowel cancer.
    Valone FH; Wittlinger PS; Flam MS; Drakes T; Eisenberg PD; Hannigan J
    Adv Exp Med Biol; 1988; 244():193-9. PubMed ID: 3073654
    [No Abstract]   [Full Text] [Related]  

  • 30. A prospective randomized trial of fluorouracil versus fluorouracil plus cisplatin in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial.
    Loehrer PJ; Turner S; Kubilis P; Hui S; Correa J; Ansari R; Stephens D; Woodburn R; Meyer S
    J Clin Oncol; 1988 Apr; 6(4):642-8. PubMed ID: 3282033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04).
    Mamounas E; Wieand S; Wolmark N; Bear HD; Atkins JN; Song K; Jones J; Rockette H
    J Clin Oncol; 1999 May; 17(5):1349-55. PubMed ID: 10334518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential 5-fluorouracil, methotrexate, and calcium leucovorin in metastatic colorectal cancer.
    Hansen RM; Banerjee TK; Davis HL; Zaentz SD; Schiferl EA; Ousley JL; Pogodzinski AE; Trump DL
    Wis Med J; 1988 May; 87(5):20-3. PubMed ID: 3291405
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
    Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ
    Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An EORTC Gastrointestinal Group phase III evaluation of combinations of methyl-CCNU, 5-fluorouracil, and adriamycin in advanced gastric cancer.
    Lacave A; Wils J; Bleiberg H; Diaz-Rubio E; Duez N; Dalesio O
    J Clin Oncol; 1987 Sep; 5(9):1387-93. PubMed ID: 3305795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer.
    Browman GP; Archibald SD; Young JE; Hryniuk WM; Russell R; Kiehl K; Levine MN
    J Clin Oncol; 1983 Dec; 1(12):787-92. PubMed ID: 6366132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report.
    Higgins GA; Amadeo JH; McElhinney J; McCaughan JJ; Keehn RJ
    Cancer; 1984 Jan; 53(1):1-8. PubMed ID: 6360325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytostatic drug therapy in disseminated colorectal cancer.
    Glimelius B; PĂ„hlman L
    Scand J Gastroenterol Suppl; 1988; 149():181-9. PubMed ID: 2974175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An aggressive, sequential combination chemotherapy regimen in the treatment of metastatic colorectal carcinoma.
    Beck TM; Hart NE; Woodard DA; Smith CE
    Prog Clin Biol Res; 1986; 216():399-405. PubMed ID: 3088599
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase II study of sequential methotrexate and 5-FU plus mitomycin and leucovorin in patients with disseminated large bowel cancer: a Northern California Oncology Group study.
    Ignoffo RJ; Friedman MA; Gribble M; Hannigan J; Reynolds R; Yu KP; Schiff S; Congdon JE
    Cancer Treat Rep; 1984; 68(7-8):983-8. PubMed ID: 6611204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of metastatic colorectal carcinoma with 5-FU, mitomycin, vincristine, and methotrexate.
    Beck TM; Curtis PW; Woodard DA; Hart NE; Smith CE
    Cancer Treat Rep; 1984 Apr; 68(4):647-50. PubMed ID: 6424937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.